EUVIMEDEUVIMED entdecken
Crossref

Myosin Light Chain Kinase–Mediated Endothelial Hyperpermeability Underlies Temsirolimus‐Induced Lung Injury

Xiaolin Chen iD, Jianhui Chen, Shuihong Liu, Danjing Yu

The FASEB Journal · 2025

DOI: 10.1096/fj.202501447r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Xiaolin Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Pingxiang People's Hospital, Gannan Medical University, Pingxiang, Jiangxi, China. Hauptthemen laut MEDLINE: Myosin-Light-Chain Kinase, Sirolimus, Endothelial Cells, Lung Injury. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangxi Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary toxicity is a common adverse effect of temsirolimus (a first‐generation mammalian target of rapamycin (mTOR) inhibitor), but its mechanisms are unclear. Disruption of endothelial‐barrier integrity is key in the pathophysiology of lung injury. We investigated the role and mechanisms of endothelial‐barrier dysfunction in the pathogenesis of temsirolimus‐induced lung injury. We evaluated the impact of temsirolimus on the permeability of human pulmonary microvascular endothelial cells (HPMECs) using transendothelial electrical resistance and albumin leakage while simultaneously investigating its effects on Ca 2+ release via ryanodine receptors (RyRs) in endothelial cells (ECs). The roles of myosin light chain kinase (MLCK) in endothelial‐barrier permeability were studied in MLCK small interfering (si)RNA‐transfected HPMECs. In addition, we established a mouse model subjected to intraperitoneal injections of temsirolimus to explore its effects on pulmonary vascular permeability and lung injury. We highlighted the contribution of the MLCK to temsirolimus‐induced vascular hyperpermeability and lung injury, supported by studies in two lines of transgenic mice with knocking out MLCK or conditional deletion of MLCK in the endothelium. Temsirolimus increased the permeability of HPMECs, which was correlated with the phosphorylation of myosin light chain (MLC), MLCK activation, and the formation of F‐actin stress fibers. Temsirolimus caused a rise in intracellular Ca 2+ leakage within HPMECs, an effect that was reversed by pretreatment with ryanodine. The latter diminished the phosphorylation of MLCK/MLC induced by temsirolimus, which subsequently led to disruption of the endothelial barrier in HPMECs. Aligning with these in vitro findings, temsirolimus administration resulted in dysfunction of the lung–vascular barrier, characterized by increased protein levels in bronchoalveolar lavage fluid (BALF) and increased permeability of the lung capillary endothelium. Mice with systemic and EC‐specific MLCK knockout exhibited reduced temsirolimus‐induced pulmonary microvascular hyperpermeability and lung injury. Temsirolimus induced pulmonary endothelial hyperpermeability mediated (at least in part) by the Ca 2+ ‐dependent MLCK/p‐MLC pathway caused EC contraction and contributed to lung injury through mTOR‐independent mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myosin-Light-Chain KinaseSirolimusEndothelial CellsLung InjuryCapillary PermeabilityEndothelium, VascularAnimalsMiceHumansCalciumMice, Inbred C57BLMice, KnockoutMice, TransgenicMaleCells, CulturedRyanodine Receptor Calcium Release Channel

Stichwörter der Autor:innen

Ca2+endothelial cellslung injurymyosin light chain kinasetemsirolimus

Substanzen

Myosin-Light-Chain KinaseSirolimustemsirolimusCalciumRyanodine Receptor Calcium Release Channel

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Pingxiang People's Hospital, Gannan Medical University, Pingxiang, Jiangxi, China.

ORCID-Profile: Xiaolin Chen

Förderung

  • Natural Science Foundation of Jiangxi Province
  • National Natural Science Foundation of China

Zitieren

APA

Chen, X., Chen, J., Liu, S., & Yu, D. (2025). Myosin Light Chain Kinase–Mediated Endothelial Hyperpermeability Underlies Temsirolimus‐Induced Lung Injury. The FASEB Journal. https://doi.org/10.1096/fj.202501447r

Vancouver

Chen X, Chen J, Liu S, Yu D. Myosin Light Chain Kinase–Mediated Endothelial Hyperpermeability Underlies Temsirolimus‐Induced Lung Injury. The FASEB Journal. 2025. doi:10.1096/fj.202501447r

BibTeX
@article{Chen2025,
  author = {Chen, Xiaolin and Chen, Jianhui and Liu, Shuihong and Yu, Danjing},
  title = {Myosin Light Chain Kinase–Mediated Endothelial Hyperpermeability Underlies Temsirolimus‐Induced Lung Injury},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202501447r}
}
Kostenlos starten →